Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2000

Moldvay J, Scheid P, Wild P, Nabil K, Siat J, Borrelly J, Marie B, Farré G, Labib T, Pottier G, Sesboüé R, Bronner C, Vignaud J M, Martinet Y, Martinet N

Abstract excerpt

Among patients with resected non-small cell lung carcinoma, about 50% will present a tumor recurrence. Thus, it would be of major importance to be able to predict and try to prevent these relapses by an active chemotherapy and/or radiotherapy. In an attempt to answer this question, the tumors of 227 patients with a surgically resected non-small cell lung carcinoma were evaluated as follows: tumors were classified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ABO Blood-Group System
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins c-bcl-2

Share to ras Proteins

Share to Receptor, ErbB-2

Share to Survival Analysis

Source

Identifiers

PMID: 10741743

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.PMID 10741743Read ↗

Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.Semantic proximity Read ↗

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.Semantic proximity Read ↗

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.Semantic proximity Read ↗

Survival in operable non-small-cell lung cancer: role of p53 mutations, tobacco smoking and asbestos exposure.Semantic proximity Read ↗

Biological prognostic and predictive factors in lung cancer.Semantic proximity Read ↗

Do molecular markers predict survival in non-small-cell lung cancer?Semantic proximity Read ↗

Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.Semantic proximity Read ↗

Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.Semantic proximity Read ↗

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.Semantic proximity Read ↗

Prediction of survival in surgical unresectable lung cancer by artificial neural networks including genetic polymorphisms and clinical parameters.Semantic proximity Read ↗

Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.Semantic proximity Read ↗

K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.